生化学工業(4548)のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 医薬品 | LAL |
|---|---|---|---|
| 売上高 | 2013/03 | 231億 | 35.1億 |
| 2014/03 | 253億 +9.6% | 42.7億 +21.6% | |
| 2015/03 | 246億 -2.7% | 48.8億 +14.2% | |
| 2016/03 | 255億 +3.5% | 54.4億 +11.6% | |
| 2017/03 | 242億 -5.4% | 54.4億 -0.1% | |
| 2018/03 | 242億 +0.4% | 59.3億 +9.1% | |
| 2019/03 | 219億 -9.7% | 64.9億 +9.4% | |
| 2020/03 | 222億 +1.2% | 64.8億 -0.2% | |
| 2021/03 | 208億 -6.2% | 69.4億 +7.2% | |
| 2022/03 | 257億 +23.6% | 91.6億 +31.9% | |
| 2023/03 | 227億 -11.6% | 107億 +17.2% | |
| 2024/03 | 259億 +14.2% | 103億 -4.3% | |
| 2025/03 | 275億 +6.1% | 119億 +15.5% | |
| 2026/03 | 245億 -11% | 122億 +2.5% | |
| 科目 | 年度 | 医薬品 | LAL |
| 営業利益 | 2013/03 | 24億 | 7.22億 |
| 2014/03 | 39.6億 +64.8% | 9.74億 +34.9% | |
| 2015/03 | 12億 -69.6% | 11.8億 +21% | |
| 2016/03 | 10.2億 -15.6% | 11.3億 -4.3% | |
| 2017/03 | 2.34億 -77% | 10.5億 -7.2% | |
| 2018/03 | 3.1億 +32.5% | 11.1億 +6.1% | |
| 2019/03 | -2.38億 赤字 | 12.2億 +9.4% | |
| 2020/03 | 11.3億 | 8.27億 -31.9% | |
| 2021/03 | 10.8億 -4.4% | 11.7億 +41% | |
| 2022/03 | 22.1億 +104.5% | 22.8億 +95.6% | |
| 2023/03 | -1.43億 赤字 | 22.6億 -1.1% | |
| 2024/03 | -3.74億 赤字 | 8.07億 -64.2% | |
| 2025/03 | 5.23億 | 8.09億 +0.2% | |
| 2026/03 | -16.4億 赤字 | 9.75億 +20.5% | |
| 科目 | 年度 | 医薬品 | LAL |
| 営業利益率 | 2013/03 | 10.4% | 20.6% |
| 2014/03 | 15.6% +5.2% | 22.8% +2.2% | |
| 2015/03 | 4.9% -10.7% | 24.2% +1.4% | |
| 2016/03 | 4% -0.9% | 20.7% -3.5% | |
| 2017/03 | 1% -3% | 19.3% -1.4% | |
| 2018/03 | 1.3% +0.3% | 18.7% -0.6% | |
| 2019/03 | -1.1% 赤字 | 18.7% ±0% | |
| 2020/03 | 5.1% | 12.8% -5.9% | |
| 2021/03 | 5.2% +0.1% | 16.8% +4% | |
| 2022/03 | 8.6% +3.4% | 24.9% +8.1% | |
| 2023/03 | -0.6% 赤字 | 21% -3.9% | |
| 2024/03 | -1.4% 赤字 | 7.9% -13.1% | |
| 2025/03 | 1.9% | 6.8% -1.1% | |
| 2026/03 | -6.7% 赤字 | 8% +1.2% | |
| 科目 | 年度 | 医薬品 | LAL |
| 固定資産増加額 | 2013/03 | 91.1億 | 0.57億 |
| 2014/03 | 70.9億 -22.1% | 1.28億 +124.6% | |
| 2015/03 | 19.4億 -72.7% | 1.56億 +21.9% | |
| 2016/03 | 16.3億 -15.8% | 3.43億 +119.9% | |
| 2017/03 | 9.16億 -43.9% | 2.57億 -25.1% | |
| 2018/03 | 13.9億 +52.2% | 1.96億 -23.7% | |
| 2019/03 | 10.3億 -25.8% | 2.76億 +40.8% | |
| 2020/03 | 15.8億 +52.7% | 5.29億 +91.7% | |
| 2021/03 | 16億 +1.6% | 5.23億 -1.1% | |
| 2022/03 | 14.6億 -8.9% | 7.32億 +40% | |
| 2023/03 | 14.6億 -0.3% | 6.34億 -13.4% | |
| 2024/03 | 37.9億 +160.6% | 10.7億 +68.3% | |
| 2025/03 | 33.6億 -11.5% | 9.73億 -8.8% | |
| 2026/03 | 55.1億 +64.2% | 6.8億 -30.1% | |
| 科目 | 年度 | 医薬品 | LAL |
| 従業員数 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | 406 | 242 | |
| 2020/03 | 527 +29.8% | 244 +0.8% | |
| 2021/03 | 545 +3.4% | 269 +10.2% | |
| 2022/03 | 553 +1.5% | 277 +3% | |
| 2023/03 | 563 +1.8% | 303 +9.4% | |
| 2024/03 | 562 -0.2% | 302 -0.3% | |
| 2025/03 | 631 +12.3% | 306 +1.3% | |
| 2026/03 | 706 +11.9% | 307 +0.3% | |
| 科目 | 年度 | 医薬品 | LAL |
| 平均臨時雇用人員 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | 95 | 13 | |
| 2020/03 | 86 -9.5% | 18 +38.5% | |
| 2021/03 | 80 -7% | 15 -16.7% | |
| 2022/03 | 76 -5% | 17 +13.3% | |
| 2023/03 | 77 +1.3% | 16 -5.9% | |
| 2024/03 | 80 +3.9% | 16 ±0% | |
| 2025/03 | 87 +8.7% | 13 -18.8% | |
| 2026/03 | 94 +8% | 13 ±0% | |
| 科目 | 年度 | 医薬品 | LAL |
| 資産 | 2013/03 | 665億 | 40.1億 |
| 2014/03 | 685億 +3% | 53.5億 +33.5% | |
| 2015/03 | 757億 +10.6% | 51.5億 -3.8% | |
| 2016/03 | 744億 -1.8% | 58.2億 +12.9% | |
| 2017/03 | 739億 -0.7% | 61.7億 +6% | |
| 2018/03 | 772億 +4.6% | 68.5億 +11.2% | |
| 2019/03 | 728億 -5.7% | 74.3億 +8.4% | |
| 2020/03 | 607億 -16.7% | 80.7億 +8.6% | |
| 2021/03 | 613億 +1% | 86.1億 +6.7% | |
| 2022/03 | 645億 +5.1% | 108億 +25.3% | |
| 2023/03 | 624億 -3.1% | 132億 +22.2% | |
| 2024/03 | 676億 +8.2% | 142億 +7.9% | |
| 2025/03 | 680億 +0.6% | 159億 +11.9% | |
| 2026/03 | 695億 +2.2% | 169億 +6% | |
| 科目 | 年度 | 医薬品 | LAL |
| 減損損失 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | - | - | |
| 2020/03 | 135億 | - | |
| 2021/03 | - | - | |
| 2022/03 | - | - | |
| 2023/03 | - | - | |
| 2024/03 | - | - | |
| 2025/03 | - | - | |
| 2026/03 | 1.69億 | - | |
| 科目 | 年度 | 医薬品 | LAL |
| のれん | 2013/03 | - | 17百万 |
| 2014/03 | - | 10百万 -41.2% | |
| 2015/03 | - | 9百万 -10% | |
| 2016/03 | - | 5百万 -44.4% | |
| 2017/03 | - | 2百万 -60% | |
| 2018/03 | - | - | |
| 2019/03 | - | - | |
| 2020/03 | 11億 | - | |
| 2021/03 | 15.3億 +38.8% | - | |
| 2022/03 | 20.9億 +36.6% | - | |
| 2023/03 | 20.9億 ±0% | - | |
| 2024/03 | 21.1億 +0.6% | - | |
| 2025/03 | 19.7億 -6.7% | - | |
| 2026/03 | 18.5億 -6.1% | - | |
| 科目 | 年度 | 医薬品 | LAL |
| のれん償却額 | 2013/03 | - | 12百万 |
| 2014/03 | - | 9百万 -25% | |
| 2015/03 | - | 2百万 -77.8% | |
| 2016/03 | - | 3百万 +50% | |
| 2017/03 | - | 2百万 -33.3% | |
| 2018/03 | - | 2百万 ±0% | |
| 2019/03 | - | - | |
| 2020/03 | - | - | |
| 2021/03 | 79百万 | - | |
| 2022/03 | 180百万 +127.8% | - | |
| 2023/03 | 176百万 -2.2% | - | |
| 2024/03 | 181百万 +2.8% | - | |
| 2025/03 | 193百万 +6.6% | - | |
| 2026/03 | 187百万 -3.1% | - |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 医薬品 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 66.3億 | 66.9億 | 66.4億 | 53.9億 | 253億 |
| 2015/03 | 62.5億 -5.8% | 55.2億 -17.5% | 66.7億 +0.5% | 62.1億 +15.3% | 246億 -2.7% | |
| 2016/03 | 63.2億 +1.1% | 68.8億 +24.7% | 61.1億 -8.4% | 62.1億 ±-0% | 255億 +3.5% | |
| 2017/03 | 67.7億 +7.2% | 55.1億 -19.9% | 57.4億 -6% | 61.3億 -1.3% | 242億 -5.4% | |
| 2018/03 | 60.6億 -10.5% | 65億 +17.9% | 66億 +15% | 50.9億 -17.1% | 242億 +0.4% | |
| 2019/03 | 55.6億 -8.3% | 53.8億 -17.2% | 57.7億 -12.5% | 51.8億 +1.8% | 219億 -9.7% | |
| 2020/03 | 59.4億 +6.8% | 63億 +17.1% | 61.1億 +5.9% | 38.2億 -26.3% | 222億 +1.2% | |
| 2021/03 | 50.2億 -15.4% | 49.6億 -21.3% | 56.1億 -8.2% | 52億 +36.3% | 208億 -6.2% | |
| 2022/03 | 97.1億 +93.3% | 64.3億 +29.7% | 52.8億 -5.8% | 42.8億 -17.8% | 257億 +23.6% | |
| 2023/03 | 54.9億 -43.5% | 62億 -3.5% | 62.6億 +18.5% | 47.7億 +11.6% | 227億 -11.6% | |
| 2024/03 | 71.7億 +30.7% | 59.2億 -4.6% | 66.4億 +6% | 62.2億 +30.3% | 259億 +14.2% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 18.9億 | 11.6億 | 11.9億 | -2.69億 | 39.6億 |
| 2015/03 | 8.01億 -57.5% | 1.57億 -86.4% | 3.65億 -69.3% | -1.19億 赤字 | 12億 -69.6% | |
| 2016/03 | 5.72億 -28.6% | 9.32億 +493.6% | 3.37億 -7.7% | -8.25億 赤字 | 10.2億 -15.6% | |
| 2017/03 | 0.29億 -94.9% | 1.79億 -80.8% | -1.7億 赤字 | 1.96億 | 2.34億 -77% | |
| 2018/03 | 6.42億 +999.99% | 10.4億 +478.2% | 7.06億 | -20.7億 赤字 | 3.1億 +32.5% | |
| 2019/03 | 2.26億 -64.8% | 1.13億 -89.1% | 0.37億 -94.8% | -6.14億 赤字 | -2.38億 赤字 | |
| 2020/03 | 6.1億 +169.9% | 9.73億 +761.1% | 8.04億 +999.99% | -12.6億 赤字 | 11.3億 | |
| 2021/03 | 0.88億 -85.6% | 3.07億 -68.4% | 5.02億 -37.6% | 1.85億 | 10.8億 -4.4% | |
| 2022/03 | 39.5億 +999.99% | 9.88億 +221.8% | -5.53億 赤字 | -21.7億 赤字 | 22.1億 +104.5% | |
| 2023/03 | 2.27億 -94.2% | 9.39億 -5% | 2.29億 | -15.4億 赤字 | -1.43億 赤字 | |
| 2024/03 | 9.71億 +327.8% | 0.91億 -90.3% | 4.81億 +110% | -19.2億 赤字 | -3.74億 赤字 | |
| 営業利益率 | 2014/03 | 28.5% | 17.3% | 17.9% | -5% | 15.6% |
| 2015/03 | 12.8% -15.7% | 2.8% -14.5% | 5.5% -12.4% | -1.9% 赤字 | 4.9% -10.7% | |
| 2016/03 | 9.1% -3.7% | 13.5% +10.7% | 5.5% ±0% | -13.3% 赤字 | 4% -0.9% | |
| 2017/03 | 0.4% -8.7% | 3.2% -10.3% | -3% 赤字 | 3.2% | 1% -3% | |
| 2018/03 | 10.6% +10.2% | 15.9% +12.7% | 10.7% | -40.8% 赤字 | 1.3% +0.3% | |
| 2019/03 | 4.1% -6.5% | 2.1% -13.8% | 0.6% -10.1% | -11.9% 赤字 | -1.1% 赤字 | |
| 2020/03 | 10.3% +6.2% | 15.4% +13.3% | 13.2% +12.6% | -32.9% 赤字 | 5.1% | |
| 2021/03 | 1.8% -8.5% | 6.2% -9.2% | 8.9% -4.3% | 3.6% | 5.2% +0.1% | |
| 2022/03 | 40.7% +38.9% | 15.4% +9.2% | -10.5% 赤字 | -50.7% 赤字 | 8.6% +3.4% | |
| 2023/03 | 4.1% -36.6% | 15.1% -0.3% | 3.7% | -32.2% 赤字 | -0.6% 赤字 | |
| 2024/03 | 13.5% +9.4% | 1.5% -13.6% | 7.2% +3.5% | -30.8% 赤字 | -1.4% 赤字 | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| LAL | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 10.2億 | 10.7億 | 10.8億 | 11億 | 42.7億 |
| 2015/03 | 13.3億 +30.6% | 11.5億 +7.6% | 11.6億 +7.3% | 12.4億 +12.1% | 48.8億 +14.2% | |
| 2016/03 | 14.5億 +8.6% | 13.1億 +13.5% | 13.8億 +18.8% | 13.1億 +6.4% | 54.4億 +11.6% | |
| 2017/03 | 15.1億 +4.2% | 13億 -0.8% | 13.1億 -5.2% | 13.3億 +1.1% | 54.4億 -0.1% | |
| 2018/03 | 14.5億 -4% | 14.9億 +14.9% | 13.1億 +0.2% | 16.9億 +27% | 59.3億 +9.1% | |
| 2019/03 | 16.7億 +15.3% | 16.5億 +10.7% | 15.6億 +19.1% | 16.2億 -4.1% | 64.9億 +9.4% | |
| 2020/03 | 17.1億 +2.8% | 16.1億 -2.7% | 15.7億 +1.1% | 15.8億 -2.1% | 64.8億 -0.2% | |
| 2021/03 | 18.4億 +7.7% | 14.6億 -9.5% | 16.6億 +5.6% | 19.8億 +25.1% | 69.4億 +7.2% | |
| 2022/03 | 20.8億 +12.6% | 23.2億 +59.3% | 23.3億 +40.3% | 24.3億 +22.7% | 91.6億 +31.9% | |
| 2023/03 | 28.2億 +35.8% | 27.5億 +18.5% | 26.4億 +13.4% | 25.2億 +3.8% | 107億 +17.2% | |
| 2024/03 | 24.9億 -11.7% | 24.8億 -9.6% | 26.9億 +1.7% | 26.1億 +3.6% | 103億 -4.3% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 2.49億 | 1.96億 | 2.98億 | 2.31億 | 9.74億 |
| 2015/03 | 3.85億 +54.6% | 2.21億 +12.8% | 3.44億 +15.4% | 2.29億 -0.9% | 11.8億 +21% | |
| 2016/03 | 3.11億 -19.2% | 2.34億 +5.9% | 3.56億 +3.5% | 2.27億 -0.9% | 11.3億 -4.3% | |
| 2017/03 | 3.5億 +12.5% | 2.24億 -4.3% | 2.68億 -24.7% | 2.05億 -9.7% | 10.5億 -7.2% | |
| 2018/03 | 2.32億 -33.7% | 3.09億 +37.9% | 2.06億 -23.1% | 3.64億 +77.6% | 11.1億 +6.1% | |
| 2019/03 | 3.03億 +30.6% | 3.21億 +3.9% | 3.51億 +70.4% | 2.4億 -34.1% | 12.2億 +9.4% | |
| 2020/03 | 3.53億 +16.5% | 2.13億 -33.6% | 3.12億 -11.1% | -0.51億 赤字 | 8.27億 -31.9% | |
| 2021/03 | 3.07億 -13% | 0.86億 -59.6% | 3.34億 +7.1% | 4.39億 | 11.7億 +41% | |
| 2022/03 | 5億 +62.9% | 6.04億 +602.3% | 7.48億 +124% | 4.29億 -2.3% | 22.8億 +95.6% | |
| 2023/03 | 8.99億 +79.8% | 5.44億 -9.9% | 5.68億 -24.1% | 2.46億 -42.7% | 22.6億 -1.1% | |
| 2024/03 | 3.27億 -63.6% | 0.93億 -82.9% | 3.65億 -35.7% | 0.22億 -91.1% | 8.07億 -64.2% | |
| 営業利益率 | 2014/03 | 24.5% | 18.3% | 27.6% | 21% | 22.8% |
| 2015/03 | 28.9% +4.4% | 19.2% +0.9% | 29.7% +2.1% | 18.5% -2.5% | 24.2% +1.4% | |
| 2016/03 | 21.5% -7.4% | 17.9% -1.3% | 25.9% -3.8% | 17.3% -1.2% | 20.7% -3.5% | |
| 2017/03 | 23.3% +1.8% | 17.3% -0.6% | 20.5% -5.4% | 15.4% -1.9% | 19.3% -1.4% | |
| 2018/03 | 16.1% -7.2% | 20.7% +3.4% | 15.8% -4.7% | 21.6% +6.2% | 18.7% -0.6% | |
| 2019/03 | 18.2% +2.1% | 19.4% -1.3% | 22.6% +6.8% | 14.8% -6.8% | 18.7% ±0% | |
| 2020/03 | 20.6% +2.4% | 13.3% -6.1% | 19.8% -2.8% | -3.2% 赤字 | 12.8% -5.9% | |
| 2021/03 | 16.6% -4% | 5.9% -7.4% | 20.1% +0.3% | 22.2% | 16.8% +4% | |
| 2022/03 | 24.1% +7.5% | 26.1% +20.2% | 32.1% +12% | 17.7% -4.5% | 24.9% +8.1% | |
| 2023/03 | 31.9% +7.8% | 19.8% -6.3% | 21.5% -10.6% | 9.8% -7.9% | 21% -3.9% | |
| 2024/03 | 13.1% -18.8% | 3.7% -16.1% | 13.6% -7.9% | 0.8% -9% | 7.9% -13.1% | |